Latest Articles

Subject

Research Article
Comparative Effects of Domain-Specific Human Monoclonal Antibodies Against LGI1 on Neuronal Excitability
Josefine Sell, Vahid Rahmati, Marin Kempfer, et al.

April 07, 2023
Research Article
Lesional Antibody Synthesis and Complement Deposition Associate With De Novo Antineuronal Antibody Synthesis After Spinal Cord Injury
Jan M. Schwab, Carmen Haider, Marcel A. Kopp, et al.

April 05, 2023
Clinical/Scientific Note
Prolonged Corticosteroids Without Maintenance Immunotherapy for Treatment of Anti-LGI1 EncephalitisAnalysis of Outcomes and Relapse Rate
Samir Alkabie, Adrian Budhram

April 04, 2023
Diagnostic & Treatment Challenges
Relapsing Encephalomyelitis After COVID-19 Infection and VaccinationFrom the National MS Society Case Conference Proceedings
Shuvro Roy, Paula Barreras, Carlos A. Pardo, et al.

April 04, 2023
Correction & Replacement
Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis
March 27, 2023
Research Article
New Insights on DR and DQ Human Leukocyte Antigens in Anti-LGI1 Encephalitis
Yahel Segal‬‏, Michal Nisnboym, Keren Regev, et al.

March 27, 2023
Research Article
Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure
Sunny Malhotra, Laura Hurtado-Navarro, Agustin Pappolla, et al.

March 27, 2023
Research Article
Retrospective Pediatric Cohort Study Validates NEOS Score and Demonstrates Applicability in Children With Anti-NMDAR Encephalitis
Marc Nikolaus, Philipp Rausch, Kevin Rostásy, et al.

March 22, 2023
Clinical/Scientific Note
TNF-Blockade for Primary Stroke Prevention in Adenosine Deaminase 2 DeficiencyA Case Series
Ariane Soldatos, Camilo Toro, Patrycja Hoffmann, et al.

March 20, 2023
Research Article
Inflammatory Activity After Diverse Fertility TreatmentsA Multicenter Analysis in the Modern Multiple Sclerosis Treatment Era
Edith L. Graham, Jennifer B. Bakkensen, Annika Anderson, et al.

March 15, 2023

Pages